☰

Gang Liu - Publications

Affiliations: 
2011 Texas A & M University, College Station, TX, United States 
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Han Z, Liu G, Wang R, Dong XQ, Zhang X. Highly efficient Ir-catalyzed asymmetric hydrogenation of benzoxazinones and derivatives with a Brønsted acid cocatalyst. Chemical Science. 10: 4328-4333. PMID 31057759 DOI: 10.1039/C8Sc05797D  0.311
2018 Francesco MED, Marszalek JR, McAfoos T, Carroll CL, Kang Z, Liu G, Theroff JP, Bardenhager JP, Bandi ML, Molina JR, Gera S, Protopopova M, Sun Y, Do MKG, Feng N, et al. Abstract 1655: Discovery and development of IACS-010759, a novel inhibitor of Complex I currently in phase I studies to exploit oxidative phosphorylation dependency in acute myeloid leukemia and solid tumors Cancer Research. 78: 1655-1655. DOI: 10.1158/1538-7445.Am2018-1655  0.302
2017 Jones P, Francesco MED, Molina JM, Protopopova M, Bandi M, Bardenhagen J, Bristow CA, Carroll CL, Feng N, Do MKG, Greer JM, Konopleva M, Kang Z, Liu G, McAfoos T, et al. Abstract PR01: IACS-010759 a novel inhibitor of oxidative phosphorylation advancing into first-in-human studies to exploit metabolic vulnerabilities Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-Pr01  0.317
2017 Molina J, Bandi M, Bardenhagen J, Bristow C, Carroll C, Chang E, Cross J, Daver N, Feng N, Do MG, Greer J, Han J, Hirst J, Huang S, Jiang Y, ... ... Liu G, et al. Abstract 4971: IACS-010759, a novel inhibitor of complex I in Phase I clinical development to target OXPHOS dependent tumors Cancer Research. 77: 4971-4971. DOI: 10.1158/1538-7445.Am2017-4971  0.305
2016 Protopopova M, Bandi M, Sun Y, Bardenhagen J, Bristow C, Carroll C, Chang E, Feng N, Do MG, Greer J, Konopleva M, Matre P, Kang Z, Liu G, Muller F, et al. Abstract A65: IACS-10759: A novel OXPHOS inhibitor that selectively kills tumors with metabolic vulnerabilities Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-A65  0.301
2016 Molina JR, Protopopova M, Bandi M, Bardenhagen J, Bristow C, Carroll C, Chang E, Feng N, Do MG, Greer J, Huang S, Jiang Y, Konopleva M, Matre P, Han J, ... ... Liu G, et al. Abstract 335: Title: IACS-010759 is a novel clinical candidate that targets AML cells by inducing a metabolic catastrophe through inhibition of oxidative phosphorylation Cancer Research. 76: 335-335. DOI: 10.1158/1538-7445.Am2016-335  0.313
2015 Protopopova M, Bandi M, Bardenhagen J, Bristow C, Carroll C, Chang E, Feng N, Do MG, Greer J, Konopleva M, Matre P, Kang Z, Liu G, Muller F, Lofton T, et al. Abstract 4380: IACS-10759: A novel OXPHOS inhibitor which selectively kill tumors with metabolic vulnerabilities Cancer Research. 75: 4380-4380. DOI: 10.1158/1538-7445.Am2015-4380  0.308
2015 Molina JR, Protopopova M, Bandi M, Bardenhagen J, Bristow C, Alimova M, Carroll C, Chang E, Feng N, Do MG, Greer J, Huang S, Jiang Y, Konopleva M, Matre P, ... ... Liu G, et al. Abstract LB-A15: IACS-010759 is a novel inhibitor of oxidative phosphorylation that selectively targets AML cells by inducing a metabolic catastrophe Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-Lb-A15  0.306
2015 Wang Y, Liu G, Reyes JCP, Duverna R. One-Pot Synthesis of 3-Cyano-2-pyridones Journal of Heterocyclic Chemistry. 52: 1185-1191. DOI: 10.1002/Jhet.2227  0.614
2014 Marszalek JR, Bandi M, Bardenhagen J, Bristow C, Carroll C, Chang E, Feng N, Czako B, Do MG, Greer J, Johnson RM, Konopleva M, Kang Z, Liu G, Lofton T, et al. Abstract 949: Identification of OXPHOS inhibitors which selectively kill tumors with specific metabolic vulnerabilities Cancer Research. 74: 949-949. DOI: 10.1158/1538-7445.Am2014-949  0.314
2013 Liu G, Shirley ME, Van KN, McFarlin RL, Romo D. Rapid assembly of complex cyclopentanes employing chiral, α,β-unsaturated acylammonium intermediates. Nature Chemistry. 5: 1049-57. PMID 24256870 DOI: 10.1038/Nchem.1788  0.526
2012 Liu G, Shirley ME, Romo D. A diastereoselective, nucleophile-promoted aldol-lactonization of ketoacids leading to bicyclic-β-lactones. The Journal of Organic Chemistry. 77: 2496-500. PMID 22260519 DOI: 10.1021/Jo202252Y  0.522
2011 Liu G, Romo D. Total synthesis of (+)-omphadiol. Angewandte Chemie (International Ed. in English). 50: 7537-40. PMID 21761524 DOI: 10.1002/Anie.201102289  0.557
2011 Liu G, Romo D. Cover Picture: Total Synthesis of (+)-Omphadiol (Angew. Chem. Int. Ed. 33/2011) Angewandte Chemie International Edition. 50: 7449-7449. DOI: 10.1002/Anie.201104527  0.54
2011 Liu G, Romo D. Titelbild: Total Synthesis of (+)-Omphadiol (Angew. Chem. 33/2011) Angewandte Chemie. 123: 7587-7587. DOI: 10.1002/Ange.201104527  0.558
2009 Liu G, Romo D. Enantioselective synthesis of schulzeines B and C via a beta-lactone-derived surrogate for bishomoserine aldehyde. Organic Letters. 11: 1143-6. PMID 19209875 DOI: 10.1021/Ol802992M  0.54
2007 Rzasa RM, Kaller MR, Liu G, Magal E, Nguyen TT, Osslund TD, Powers D, Santora VJ, Viswanadhan VN, Wang HL, Xiong X, Zhong W, Norman MH. Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Bioorganic & Medicinal Chemistry. 15: 6574-95. PMID 17697781 DOI: 10.1016/j.bmc.2007.07.005  0.623
Show low-probability matches.